Gefitinib (‘Iressa’, ZD1839) is active against brain metastases in a 77 year old patient-Reference-Cited by-同舟云学术

Gefitinib (‘Iressa’, ZD1839) is active against brain metastases in a 77 year old patient

Published:2005-02 Issue:3 Volume:71 Page:277-280
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Roggero Enrico,Giancarla Busi,Antonella Palumbo,Augusto Pedrazzini

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-004-1719-x.pdf

Reference4 articles.

1. Vaporciyan AA, Nesbitt JC, Lee JS, Stevens CW, Komaki R, Roth JA: Cancer of the Lung. In: Bast RC, Kufe DW, Pollock RE, Weichselbaum RR, Holland JF, Frei EI (eds) Cancer Medicine-5 Review. American Cancer Society and B.C. Decker Inc., pp 1227--1292, 2000

2. Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Targeted Therapies and Central Nervous System (CNS) Metastases;CNS Drugs;2015-11

2. Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance;Drug Resistance Updates;2012-02

3. An Unexpected Synergist Role of P-Glycoprotein and Breast Cancer Resistance Protein on the Central Nervous System Penetration of the Tyrosine Kinase Inhibitor Lapatinib (N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine; GW572016): TABLE 1;Drug Metabolism and Disposition;2008-12-04

4. Gefitinib is effective for pathological fracture of metastatic non-small cell lung cancer;European Journal of Orthopaedic Surgery & Traumatology;2008-11-25

5. Recent advances in the treatment of central nervous system tumors;Update on Cancer Therapeutics;2008-03